Latest from Pharmablogology
Spinal muscular atrophy and Zolgensma
Reports have appeared in the UK media of the NHS administering the most expensive drug in the world to a 5-month-old boy. Onasemnogene abeparvovec (sold as Zolgensma), costing around two and a half million US-dollars (£1.79 million),* is a gene therapy agent to treat spinal muscular atrophy. The headlines quoted the price but gave scantContinue reading “Spinal muscular atrophy and Zolgensma”
Loading…
Something went wrong. Please refresh the page and/or try again.
Welcome to Graham Lappin’s Pharmablogoloy Science Blog. I cover many aspects of science with a focus on biochemistry and pharmacology. I try to translate the jargon for the non-expert and always have an eye on exposing pseudoscientific nonsense.
I have a YouTube channel primarily for pharmacokinetics lectures originating from my time at the University of Lincoln
Opening theme music by my daughter-in-law Niki Lappin
